Add Experiment


[{"result":"Decrease","is_hypothetical":"false","stat_test":"generalized linear mixed model","measure":"Young Adult Self Report (YASR)","condition":"Neurofibromatosis type I","sample_size":23,"age_min":18,"dose_max":80,"dose_min":40,"age_max":50,"OutcomeNotes":"Internalizing Problems subscale","duration":"98","paper_uuid":"2f48d25b-f49a-4a6a-807f-e60b8392c981","priority":"Secondary","experiment":"Positive","InterventionNotes":"dose-escalating approach","uuid":"36715cfd-18d0-4449-9a35-d0f38cd14e90","p_value":0.03,"intervention":"lovastatin","outcome":"internalising behavioral problems","type":"INHIBITS"},{"result":"Decrease","is_hypothetical":"false","stat_test":"generalized linear mixed model","measure":"Young Adult Self Report (YASR)","condition":"Neurofibromatosis type I","sample_size":23,"age_min":10,"dose_max":40,"dose_min":20,"age_max":17,"OutcomeNotes":"Internalizing Problems subscale","duration":"98","paper_uuid":"2f48d25b-f49a-4a6a-807f-e60b8392c981","priority":"Secondary","experiment":"Positive","InterventionNotes":"dose-escalating approach","uuid":"6de177eb-599a-4293-9039-dfe321b3c30a","p_value":0.03,"intervention":"lovastatin","outcome":"internalising behavioral problems","type":"INHIBITS"},{"result":"Increase","is_hypothetical":"false","stat_test":"generalized linear mixed model","measure":"Hopkins Verbal Learning Test","condition":"Neurofibromatosis type I","sample_size":23,"age_min":18,"dose_max":80,"dose_min":40,"age_max":50,"duration":"98","paper_uuid":"2f48d25b-f49a-4a6a-807f-e60b8392c981","priority":"Secondary","experiment":"Positive","InterventionNotes":"dose-escalating approach","uuid":"dea2847b-2938-4769-9690-5f846895e46b","p_value":0.02,"intervention":"lovastatin","outcome":"verbal declarative memory","type":"EXCITES"},{"result":"Increase","is_hypothetical":"false","stat_test":"generalized linear mixed model","measure":"Hopkins Verbal Learning Test","condition":"Neurofibromatosis type I","sample_size":23,"age_min":10,"dose_max":40,"dose_min":20,"age_max":17,"duration":"98","paper_uuid":"2f48d25b-f49a-4a6a-807f-e60b8392c981","priority":"Secondary","experiment":"Positive","InterventionNotes":"dose-escalating approach","uuid":"dea28c1a-8d02-493c-806f-6c8624851950","p_value":0.02,"intervention":"lovastatin","outcome":"verbal declarative memory","type":"EXCITES"},{"result":"Increase","is_hypothetical":"false","stat_test":"generalized linear mixed model","measure":"Letter-Number Sequencing task","condition":"Neurofibromatosis type I","sample_size":23,"age_min":18,"dose_max":80,"dose_min":40,"age_max":50,"duration":"98","paper_uuid":"2f48d25b-f49a-4a6a-807f-e60b8392c981","priority":"Primary","experiment":"Positive","InterventionNotes":"dose-escalating approach","uuid":"421497cd-026f-4d0d-bfb3-7e378f578cea","p_value":0.01,"intervention":"lovastatin","outcome":"working memory","type":"EXCITES"},{"result":"Increase","is_hypothetical":"false","stat_test":"generalized linear mixed model","measure":"Letter-Number Sequencing task","condition":"Neurofibromatosis type I","sample_size":23,"age_min":10,"dose_max":40,"dose_min":20,"age_max":17,"duration":"98","paper_uuid":"2f48d25b-f49a-4a6a-807f-e60b8392c981","priority":"Primary","experiment":"Positive","InterventionNotes":"dose-escalating approach","uuid":"5f8f7b6f-9dd0-48b0-9169-d0ad5831ec54","p_value":0.01,"intervention":"lovastatin","outcome":"working memory","type":"EXCITES"}]
IDActionsWhat AgentWhere AgentWhen AgentExperimentAgent ApproachWhat TargetWhere TargetWhen TargetResultTarget ApproachConnection TypeWhat Second AgentWhere Second AgentWhen Second AgentSecond Agent ManipulationSecond Agent Approach

working memory